BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16909969)

  • 1. Age and bromodeoxyuridine labelling index as prognostic factors in high-grade gliomas treated with surgery and radiotherapy.
    Gasinska A; Skolyszewski J; Glinski B; Niemiec J; Adamczyk A; Krzyszkowski T; Zabek M
    Clin Oncol (R Coll Radiol); 2006 Aug; 18(6):459-65. PubMed ID: 16909969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of DNA ploidy and proliferation rate in human astrocytic gliomas.
    Gasińska A; Krzyszk wski T; Niemiec J; Adamczyk A; Skołyszewski J
    Folia Histochem Cytobiol; 2000; 38(4):175-80. PubMed ID: 11185722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric analysis of DNA ploidy and proliferative potential in brain tumours.
    Gasińska A; Krzyszkowski T; Skołyszewski J; Biesaga B; Gliński B; Pyrich M
    Folia Histochem Cytobiol; 1998; 36(3):133-8. PubMed ID: 9773297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour cell kinetics as a prognostic factor in squamous cell carcinoma of the cervix treated with radiotherapy.
    Gasińska A; Urbański K; Jakubowicz J; Klimek M; Biesaga B; Wilson GD
    Radiother Oncol; 1999 Jan; 50(1):77-84. PubMed ID: 10225560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic relevance of cell proliferation markers and DNA-ploidy in gliomas.
    Struikmans H; Rutgers DH; Jansen GH; Tulleken CA; van der Tweel I; Battermann JJ
    Acta Neurochir (Wien); 1998; 140(2):140-7. PubMed ID: 10398993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromodeoxyuridine labeling index in glioblastoma multiforme: relation to radiation response, age, and survival.
    Barker FG; Prados MD; Chang SM; Davis RL; Gutin PH; Lamborn KR; Larson DA; McDermott MW; Sneed PK; Wilson CB
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):803-8. PubMed ID: 8598356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential doubling time in head and neck tumors treated by primary radiotherapy: preliminary evidence for a prognostic significance in local control.
    Corvò R; Giaretti W; Sanguineti G; Geido E; Orecchia R; Barra S; Margarino G; Bacigalupo A; Vitale V
    Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1165-72. PubMed ID: 8262843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of cell kinetics as predictive factor of response to radiotherapy alone or chemoradiotherapy in patients with advanced head and neck cancer.
    Corvò R; Paoli G; Giaretti W; Sanguineti G; Geido E; Benasso M; Margarino G; Vitale V
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):57-63. PubMed ID: 10758305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour proliferation and apoptosis in human uterine cervix carcinoma II: correlations with clinical outcome.
    Tsang RW; Wong CS; Fyles AW; Levin W; Manchul LA; Milosevic M; Chapman W; Li YQ; Pintilie M
    Radiother Oncol; 1999 Jan; 50(1):93-101. PubMed ID: 10225562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry.
    Wilson GD; McNally NJ; Dunphy E; Kärcher H; Pfragner R
    Cytometry; 1985 Nov; 6(6):641-7. PubMed ID: 4064843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relations of proliferative activities of gastric carcinoma cells to lymphatic involvement, venous invasion and prognosis.
    Wu YF; Xu HM; Chen JQ
    Chin Med J (Engl); 2004 Oct; 117(10):1530-5. PubMed ID: 15498378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of proliferation indices: a study with in vivo bromodeoxyuridine and Ki-67.
    Goodson WH; Moore DH; Ljung BM; Chew K; Mayall B; Smith HS; Waldman FM
    Breast Cancer Res Treat; 2000 Jan; 59(2):113-23. PubMed ID: 10817346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of cell kinetics in cervical tumours using bromodeoxyuridine.
    Bolger BS; Cooke TG; Symonds RP; MacLean AB; Stanton PD
    Br J Cancer; 1993 Jul; 68(1):166-71. PubMed ID: 8318408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry.
    Riccardi A; Danova M; Wilson G; Ucci G; Dörmer P; Mazzini G; Brugnatelli S; Girino M; McNally NJ; Ascari E
    Cancer Res; 1988 Nov; 48(21):6238-45. PubMed ID: 3167869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
    Meyer JS; Gersell DJ; Yim S
    Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal conditions for immunohistochemical determination of the in vitro DNA synthesis labelling index with bromodeoxyuridine in head and neck cancer.
    Browman GP; Kanclerz A; Booker L; Daya D; Archibald SD; Young JE; Goldsmith CH
    Cell Prolif; 1991 Nov; 24(6):579-85. PubMed ID: 1764538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-phase fraction, 5-bromo-2'-deoxy-uridine labelling index, duration of S-phase, potential doubling time, and DNA index in benign and malignant brain tumors.
    Struikmans H; Rutgers DH; Jansen GH; Tulleken CA; van der Tweel I; Battermann JJ
    Radiat Oncol Investig; 1997; 5(4):170-9. PubMed ID: 9327496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the correlations of cell proliferation activity with lymphatic and vascular invasion and prognosis in gastric carcinoma].
    Wu YF; Xu HM; Chen JQ
    Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):492-5. PubMed ID: 16188150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of waiting for radiotherapy for grade III/IV gliomas.
    Do V; Gebski V; Barton MB
    Radiother Oncol; 2000 Nov; 57(2):131-6. PubMed ID: 11054516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of pretreatment cell kinetic parameters as predictors for radiotherapy outcome in head and neck cancer: a multicenter analysis.
    Begg AC; Haustermans K; Hart AA; Dische S; Saunders M; Zackrisson B; Gustaffson H; Coucke P; Paschoud N; Hoyer M; Overgaard J; Antognoni P; Richetti A; Bourhis J; Bartelink H; Horiot JC; Corvo R; Giaretti W; Awwad H; Shouman T; Jouffroy T; Maciorowski Z; Dobrowsky W; Struikmans H; Wilson GD
    Radiother Oncol; 1999 Jan; 50(1):13-23. PubMed ID: 10225552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.